1887

Abstract

A selection of human sera were tested for the presence of antibodies that neutralized infectious human papillomavirus (HPV) type 11. Neutralizing antibodies were detected by prevention of HPV-11-induced condylomatous transformation of human foreskin chips transplanted subrenally into athymic mice. Test sera were obtained from 21 female patients with genital condylomas and eight patients with laryngeal papillomas. Control patients consisted of 57 adult random blood donors and five asymptomatic children. ELISAs demonstrated that all sera from patients with genital papillomas were strongly reactive to disrupted papillomavirus (PV) antigens of HPV-11, bovine PV type 1 and cottontail rabbit PV, but only two were weakly reactive to intact HPV-11. None of the eight sera from the laryngeal papilloma bearers reacted significantly to disrupted PV antigens, but four of the eight showed strong specific responses to intact HPV-11 only. The majority of the sera that were reactive to intact HPV-11 by ELISA neutralized HPV-11 infectivity in the athymic mouse xenograft system. The data indicated that ELISA reactivity to intact HPV-11 virions was a good predictor for the presence of HPV-11 neutralizing antibodies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-5-1261
1992-05-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/5/JV0730051261.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-5-1261&mimeType=html&fmt=ahah

References

  1. Almeida J. D., Oriel J. D., Stannard L. M. 1969; Characterization of the virus found in human genital warts. Microbios 1:225–232
    [Google Scholar]
  2. Anisimová E., Barták P., VlČek D., Hirschl I., Břicháček B., Vonka V. 1990; Presence and type specificity of papillomavirus antibodies demonstrable by immunoelectron microscopy tests in samples from patients with warts. Journal of General Virology 71:419–422
    [Google Scholar]
  3. Baird P. J. 1986; Serological evidence for the association of papilloma virus and cervical neoplasia. In Herpes and Papillomaviruses vol 31 pp 83–92 Edited by DePalo G., Rilke F., zur Hausen H. New York: Raven Press;
    [Google Scholar]
  4. Beiss B. K., Sundberg J. P., Douglas J. M., Burk R. D., Ritter D. B., Kadish A. S. 1987; Host immune responses to genital and laryngeal human papillomavirus infections. In Cancer cells vol 5 pp 387–392 Edited by Steinberg B. M., Brandsma J. L., Taichman L. B. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  5. Bonnez W., Da Rin C., Rose R. C., Reichman R. C. 1991; Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. Journal of General Virology 72:1343–1347
    [Google Scholar]
  6. Cason J., Patel D., Naylor J., Lunney D., Shepherd P. S., Best J. M., McCance D. J. 1989; Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. Journal of General Virology 70:2973–2987
    [Google Scholar]
  7. Christensen N. D., Kreider J. W. 1990; Antibody-mediated neutralization in vivo of infectious papillomaviruses. Journal of Virology 64:3151–3156
    [Google Scholar]
  8. Christensen N. D., Kreider J. W., Cladel N. M., Galloway D. A. 1990a; Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially-derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. Virology 175:1–9
    [Google Scholar]
  9. Christensen N. D., Kreider J. W., Cladel N. M., Patrick S. D., Welsh P. A. 1990b; Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. Journal of Virology 64:5678–5681
    [Google Scholar]
  10. Cowsert L. M., Lake P., Jenson A. B. 1987; Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. Journal of the National Cancer Institute 79:1053–1058
    [Google Scholar]
  11. Cubie H. A., Norval M. 1988; Humoral and cellular immunity to papillomavirus in patients with cervical dysplasia. Journal of Medical Virology 24:85–95
    [Google Scholar]
  12. de Villiers E. M., Wagner D., Schneider A., Wesch H., Miklaw H., Wahrendorf J., Papendick U., zur Hausen H. 1987; Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet ii:703–706
    [Google Scholar]
  13. Dillner J. 1990; Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. International Journal of Cancer 46:703–711
    [Google Scholar]
  14. Dillner J., Dillner L., Robb J., Willems J., Jones I., Lancaster W., Smith R., Lerner R. 1989; A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences, U.S.A. 86:3838–3841
    [Google Scholar]
  15. Dillner J., Dillner L., Utter G., Eklund C., Rotola A., Costa S., di Luca D. 1990; Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. International Journal of Cancer 45:529–535
    [Google Scholar]
  16. Dillner L., Bekassy Z., Jonsson N., Morenzo-Lopez J., Blomberg J. 1989; Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. International Journal of Cancer 43:36–40
    [Google Scholar]
  17. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. 1983; A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsies from different geographic regions. Proceedings of the National Academy of Sciences, U.S.A. 80:3812–3815
    [Google Scholar]
  18. Favre M., Breitburd F., Croissant O., Orth G. 1975; Structural polypeptides of rabbit, bovine and human papillomaviruses. Journal of Virology 15:1239–1247
    [Google Scholar]
  19. Firzlaff J. M., Kiviat N. B., Beckmann A. M., Jenison S. A., Galloway D. A. 1988; Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames. Virology 164:467–477
    [Google Scholar]
  20. Hollinger P. H., Schild J. A., Maurizi D. G. 1968; Laryngeal papilloma: review of etiology and therapy. Laryngoscopy 78:1462–1474
    [Google Scholar]
  21. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. 1988; Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. Journal of Virology 62:2115–2123
    [Google Scholar]
  22. Jenison S. A., Yu X.-P., Valentine J. M., Galloway D. A. 1989; Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. Journal of Virology 63:809–818
    [Google Scholar]
  23. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K. E., Seedorf K., Gissman L. 1989; Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. Journal of the National Cancer Institute 81:1698–1703
    [Google Scholar]
  24. Koss L. G., Durfee G. R. 1956; Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Annals of the New York Academy of Science 63:1245–1261
    [Google Scholar]
  25. Kreider J. W., Howett M. K., Wolfe S. A., Bartlett G. L., Zaino R. J., Sedlacek T. V., Mortel R. 1985; Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature, London 317:639–640
    [Google Scholar]
  26. Kreider J. W., Howett M. K., Leure-Dupree A. E., Zaino R. J., Weber J. A. 1987; Laboratory production in vivo of infectious human papillomavirus type 11. Journal of Virology 61:590–593
    [Google Scholar]
  27. Kreider J. W., Zaino R., Welsh P. A., Patrick S. D. 1990; Host factors regulating survival and growth of HPV-transformed human cells. In Papillomaviruses pp 199–209 Edited by Howley P. M., Broker T. R. New York: Wiley-Liss;
    [Google Scholar]
  28. Li C. C. H., Shah K. V., Seth A., Gilden R. V. 1987; Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. Journal of Virology 61:2684–2690
    [Google Scholar]
  29. Lorincz A. T., Temple G. F., Patterson J. A., Jenson A. B., Kurman R. J., Lancaster W. D. 1986; Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstetrics and Gynecology 68:508–512
    [Google Scholar]
  30. Mounts P., Shah K. V., Kashima H. 1982; Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proceedings of the National Academy of Sciences, U.S.A. 79:5424–5429
    [Google Scholar]
  31. Müller M., Gausepohl H., de Martynoff G., Frank R., Brasseur R., Gissmann L. 1990; Identification of seroreactive regions of the human papillomavirus type 16 proteins E4, E6, E7 and L1. Journal of General Virology 71:2709–2717
    [Google Scholar]
  32. Pfister H. 1984; Biology and biochemistry of papillomaviruses. Reviews of Physiology Biochemistry and Pharmacology 99:111–181
    [Google Scholar]
  33. Portolani M., Mantovani G., Pietrosemoli P., Cermelli C., Boselli F. 1987; Antibodies to papillomavirus genus-antigens in women with genital warts. Microbiologica 10:271–279
    [Google Scholar]
  34. Rando R. F., Groff D. E., Chirikjian J. G., Lancaster W. D. 1986; Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. Journal of Virology 57:353–356
    [Google Scholar]
  35. Steele J. C., Gallimore P. H. 1990; Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174:388–398
    [Google Scholar]
  36. Strike D. G., Bonnez W., Rose R. C., Reichman R. C. 1989; Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the ‘common antigen’ region. Journal of General Virology 70:543–555
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-5-1261
Loading
/content/journal/jgv/10.1099/0022-1317-73-5-1261
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error